Overall market sentiment has been high on Organogenesis Holdings Inc (ORGO) stock lately. ORGO receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.
Organogenesis Holdings Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ORGO!
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.
InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.
The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.
What's Happening With ORGO Stock Today?
Organogenesis Holdings Inc (ORGO) stock has risen 3.2% while the S&P 500 has fallen -0.38% as of 9:50 AM on Monday, Nov 13. ORGO has gained $0.07 from the previous closing price of $2.19 on volume of 121,860 shares. Over the past year the S&P 500 has gained 11.15% while ORGO has fallen -20.70%. ORGO earned $0.08 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 30.12.
To screen for more stocks like Organogenesis Holdings Inc click here.
More About Organogenesis Holdings Inc
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Click Here to get the full Stock Report for Organogenesis Holdings Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
